Literature DB >> 16328720

A nationwide epidemiologic study of breast cancer incidence following breast reduction surgery in a large cohort of Swedish women.

Jon P Fryzek1, Weimin Ye, Olof Nyrén, Robert E Tarone, Loren Lipworth, Joseph K McLaughlin.   

Abstract

While it has been demonstrated that prophylactic mastectomy reduces breast cancer incidence among women at high risk, many women often consider this disfiguring surgery unacceptable. One alternative approach may be breast reduction surgery. In order to evaluate the long-term incidence of breast cancer following surgical removal of breast tissue, we have extended by 9 years the follow-up period of our earlier retrospective cohort study of Swedish women electing cosmetic breast reduction surgery (n=30,444) between 1965 and 1993, yielding an average of nearly 16 years of follow-up. Cancer incidence through 2002 was ascertained via the Swedish Cancer Registry. Standardized incidence ratios (SIRs) and 95% confidence intervals (CIs) were calculated comparing women who underwent breast reduction surgery with women in the general Swedish population. Breast cancer was observed in 443 women versus 624 expected for a statistically significant reduced SIR of 0.71 (95% CI=0.65-0.78). Analyses by age at surgery, time since surgery or calendar year of surgery revealed similar reductions in risk. Our study of over 30,000 women with long-term follow-up offers further evidence that women undergoing breast reduction surgery have reduced breast cancer risk. As the evidence from large-scale cohort studies accumulates, direct testing of this reduction in risk through clinical trials should be considered.

Entities:  

Mesh:

Year:  2005        PMID: 16328720     DOI: 10.1007/s10549-005-9099-2

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  7 in total

1.  Antihypertensive medication use and incident breast cancer in women.

Authors:  Elizabeth E Devore; Sung Kim; Cody A Ramin; Lani R Wegrzyn; Jennifer Massa; Michelle D Holmes; Karin B Michels; Rulla M Tamimi; John P Forman; Eva S Schernhammer
Journal:  Breast Cancer Res Treat       Date:  2015-02-21       Impact factor: 4.872

2.  Incidental Findings in Reduction Mammoplasty Specimens in Patients with No Prior History of Breast Cancer. An Analysis of 783 Specimens.

Authors:  Pedro Luiz Serrano Usón Junior; Donato Callegaro Filho; Diogo Diniz Gomes Bugano; Felipe Correa Geyer; Marcus Vinicius de Nigro Corpa; Paulo David Scatena Gonçalves; Sergio Daniel Simon; Rafael Aliosha Kaliks
Journal:  Pathol Oncol Res       Date:  2017-04-08       Impact factor: 3.201

3.  Influence of Breast Reduction Surgery on Long-Term Breast Cancer Risk in Austria.

Authors:  Albert Niepel; Sven Schwake; Mira Zeichmann; Ariel Noltze; Viktoria König; Fuat Sokullu; Clara Schenk; Shanon Pallikunnel; Dirk Hellekes; Rupert Koller; Lara Steinkellner
Journal:  Breast Care (Basel)       Date:  2021-07-15       Impact factor: 2.268

4.  Breast reduction surgery in Ontario: Changes in practice, 1992 to 2008.

Authors:  Bisher Alshanawani; Nawarah Alarfaj; Feras Alshomer; Muhammad Mamdani; Tara Gomes; James Mahoney
Journal:  Can J Plast Surg       Date:  2013

Review 5.  Risk-reducing mastectomy for the prevention of primary breast cancer.

Authors:  Nora E Carbine; Liz Lostumbo; Judi Wallace; Henry Ko
Journal:  Cochrane Database Syst Rev       Date:  2018-04-05

6.  Age, estrogen, and immune response in breast adenocarcinoma and adjacent normal tissue.

Authors:  David A Quigley; Andliena Tahiri; Torben Lüders; Margit H Riis; Allan Balmain; Anne-Lise Børresen-Dale; Ida Bukholm; Vessela Kristensen
Journal:  Oncoimmunology       Date:  2017-08-10       Impact factor: 8.110

7.  Incidence of occult carcinoma and high-risk lesions in mammaplasty specimens.

Authors:  Beth C Freedman; Sharon M Rosenbaum Smith; Alison Estabrook; Jasminka Balderacchi; Paul I Tartter
Journal:  Int J Breast Cancer       Date:  2012-10-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.